| Financial Year |
March 31 2023 |
| Monetary Funds |
237,356,625.63 |
| Held-for-trading Financial Assets |
36,120.00 |
| Notes Receivable |
26,964,500.00 |
| Accounts Receivable |
14,729,159.11 |
| Advances to Suppliers |
1,068,039.94 |
| Other Receivables |
242,729,455.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
7,579,684.03 |
| Dividend Receivable |
-- |
| Inventories |
379,156.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,060,458,580.52 |
| Other Current Assets |
209,106,567.06 |
| Total Current Assets |
1,792,828,204.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
823,424,080.56 |
| Long-term Equity Investment |
479,534,248.76 |
| Investment Properties |
152,583,077.75 |
| Fixed Assetes |
22,710,245.15 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,166,981.33 |
| R&D expenses |
-- |
| Goodwill |
55,913,332.79 |
| Long-Term Deferred and Prepaid Expenses |
86,657.03 |
| Deferred Income Tax Assets |
70,472,096.92 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,475,766,433.91 |
| Total Assets |
4,268,594,638.11 |
| Short-Term Loans |
650,998,151.07 |
| Trading Financial liabilities |
-- |
| Notes Payable |
70,900,000.00 |
| Accounts Payable |
1,926,468.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,895,072.76 |
| Taxes Payable |
56,843,413.79 |
| Interest Payable |
-- |
| Dividend Payable |
250,000.00 |
| Other payables |
242,878,678.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
496,052,406.92 |
| Other Current Liabilities |
67,810,251.67 |
| Sub-Total of Current Liabilities |
1,597,017,053.90 |
| Long-term Loans |
420,170,921.53 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
153,458,536.12 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,238,761.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
588,912,627.05 |
| Total Liabilities |
2,185,929,680.95 |
| Paid-In Capital(Or Share Stock) |
512,727,632.00 |
| Capital Surplus |
522,560,097.27 |
| Surplus Reserve |
73,132,481.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-128,362,219.05 |
| Minority Stockholder's Interest |
1,060,660,380.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,022,004,576.59 |
| Owner's Equity（Stockholder's Equity） |
2,082,664,957.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,268,594,638.11 |
